Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc is strategically positioned in the biotechnology sector with its Enhanced Delivery Oligonucleotide platform, which significantly enhances the therapeutic potential of oligonucleotide treatments for severe neuromuscular and neurological diseases. The company’s lead product candidates exhibit a strong efficacy profile, with a reported 53.7% splicing correction in DM1, surpassing competitors and suggesting a promising future for muscle performance improvements upon further dosing trials. Given the current trading price of approximately $4 per share and the anticipation of positive multi-dose data, there is substantial potential for value appreciation as the market recognizes PepGen's unique therapeutic advancements and ongoing pipeline development.

Bears say

The financial analysis indicates a negative outlook for PepGen Inc., primarily due to a recent model update that resulted in a reduced target valuation of $8 per share, reflecting a $1 decrease. Despite advancements in its drug development, particularly with promising DM1 data, the company's market capitalization remains significantly discounted compared to peers like Dyne, highlighting a potential inadequacy in capturing its true value amid competitive pressures. Furthermore, concerns around the company's ability to execute commercially and secure necessary funding from capital markets could jeopardize ongoing development efforts, posing risks for investors.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.